Insiders · Profile

Klee Justin B.

Co-Chief Executive Officer at Amylyx Pharmaceuticals. Filing since 6 Jan 2023. CIK 0001898314

Company
Date
Role
Action
Shares
Amount
Of holding
10 Sep 2026
Co-Chief Executive Officer
Sold at will
30,464
$980.26K
0.8%
2 Mar 2026
Co-Chief Executive Officer
Sold at will
29,282
$423.76K
0.9%
2 Feb 2026
Co-Chief Executive Officer
Sold at will
15,500
$227.62K
0.5%
16 Jan 2026
Co-Chief Executive Officer
Sold at will
1,995
$27.70K
0.1%
15 Jan 2026
Co-Chief Executive Officer
Sold at will
136,193
$1.85M
3.9%
6 Jan 2026
Co-Chief Executive Officer
Sold at will
7,715
$85.59K
0.2%
30 Sep 2025
Co-Chief Executive Officer
Sold at will
29,975
$430.95K
0.9%
31 Mar 2025
Co-Chief Executive Officer
Sold at will
21,490
$74.45K
0.6%
3 Mar 2025
Co-Chief Executive Officer
Sold at will
4,595
$14.48K
0.1%
3 Feb 2025
Co-Chief Executive Officer
Sold at will
11,855
$41.10K
0.4%
6 Jan 2025
Co-Chief Executive Officer
Sold at will
7,471
$30.20K
0.2%
30 Sep 2024
Co-Chief Executive Officer
Sold at will
18,589
$59.43K
0.6%
5 Mar 2024
Co-Chief Executive Officer
Sold at will
4,135
$77.44K
0.1%
9 Jan 2024
Co-Chief Executive Officer
Sold at will
5,841
$95.37K
0.2%
16 Mar 2023
Co-Chief Executive Officer
Sold at will
100,000
$3.19M
3.5%
6 Jan 2023
Co-Chief Executive Officer
Bought
5,968
$216.63K
0.2%
16 decisions on file.